Olumiant (baricitinib)
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis.
On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Ondexxya (andexanet alfa)
Ondexxya (andexanet alfa) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.
Onivyde (irinotecan hydrochloride trihydrate)
Opzelura (ruxolitinib)
Opzelura (ruxolitinib) is a prescription cream used on the skin (topical) for:
- (short-term) treatment of chronic mild to moderate eczema (atopic dermatitis) in patients 12 years or older who aren’t suitable for or have failed other topical prescription drugs (approved by the FDA on Sept 21, 2021);
- Treatment of non-segmental vitiligo in adults and children over 12 years of age (approved by the EMA on April, 2023).
Orilissa (elagolix)
Orkambi* (lumacaftor/ivacaftor)
Orladeyo (berotralstat)
Oxbryta (voxelotor)
Oxbryta (voxelotor) is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease in adults and children 12 years of age and older.
This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
NOTE: This medicine can only be purchased on behalf of a hospital. Additional documents may be required. Please contact us for details.
Oxlumo (lumasiran)
Oxlumo (lumasiran) is a medication used to lower urinary oxalate levels in children and adults with primary hyperoxaluria type 1 (PH1).
It is the first-ever therapy available for the treatment of patients with PH1.
NOTE: This medicine can only be purchased on behalf of a hospital. Additional documents may be required. Please contact us for details.
Palynziq (pegvaliase-pqpz)
